Home / Knowledge Center /

Illumina TruSight Oncology 500 ctDNA

The Illumina TruSight Oncology 500 circulating tumor DNA (ctDNA) assay is an NGS-based assay that enables comprehensive genomic profiling to assess multiple variant types in 523 cancer-related genes from cell-free DNA (cfDNA). This assay features the same DNA content as the TruSight Oncology 500 solid tumor assay for detection of single nucleotide variants (SNVs), indels, copy number variants (CNVs), DNA fusions, tumor mutational burden (TMB), and microsatellite instability (MSI) from plasma samples.

In addition, the DRAGEN Bio-IT Platform offers speed and accuracy to detect variants detections through its ultra-rapid variant calling algorithm.

Download the technical sheet to find out more.

View Resource

Please complete this form to view the Article

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies